Completed clinical trials
| Study (Acronym) & Study Type | Sponsor/Client | Study Director/SDP | Staff (IBE) |
|---|---|---|---|
| ACEI-COVID: Stopping ACE-inhibitors in COVID-19: A Randomized Controlled Trial | Med. University Innsbruck | PD Dr. K. Rizas Prof. Dr. S. Massberg | Prof. Dr. U. Mansmann |
| ACUZoster: Phase III: Optimization of Treatment for Herpes Zoster | LMU Hospital | PD Dr. D. Irnich (Schmerzambulanz) | NN |
| ALCAT: Efficacy of Acetyl-DL-Leucine in Patients with Cerebellar Ataxia: A Randomized, Double-Blind, Placebo-Controlled, Phase III Crossover Study | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Dr. C. Adrion |
| ALTERNATIVE: A chemotherapy-free combination of the Bruton's Tyrosine Kinase Inhibitor, Ibrutinib in combination with GA 101 in patients with previously untreated follicular lymphoma and a high tumor burden | LMU Hospital - Med III | Prof. Dr. M. Dreyling | Prof. Dr. E. Hoster Dr. V. Jurinovic |
| APPROACH: Apixaban versus Phenprocoumon: Oral anticoagulation plus antiplatelet therapy in patients with acute coronary syndrome and atrial fibrillation | LMU Hospital - Med I | PD Dr. R. Wakili | Dr. A. Crispin |
| ArthroMark: Biomarkers and imaging for diagnosis, monitoring and stratification of rheumatoid arthritis and spondyloarthritides | Charité Berlin | Prof. Dr. G. Burmester | Lien Le |
| BEMED: Treatment of Meniere's Disease with Betahistine—A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Dr. C. Adrion |
| BETAVEST: Effects of Betahistine on Central Vestibular Compensation in Acute Unilateral Vestibulopathy: A Double-Blind, Placebo-Controlled Clinical Trial | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Dr. C. Adrion |
| BMP2: Phase III: Bone Formation During Spinal Fusion | BG Hospital Halle | Prof. Dr. HJ Meisel (Halle) | Prof. Dr. U. Mansmann |
| BMS-Studienvergleich: Comparative Analysis of DASISION with ENESTnd | Bristol-Myers Squibb | Dr. I. Abraham | Prof. Dr. M. Pfirrmann |
| BODO: Multicenter, open-label single arm phase II study testing the tolerability and the efficacy of Bosutinib step-in dosing in Chronic Phase CML patients intolerant or refractory to previous Nilotinib or Dasatinib therapy | Rheinische Friedrich- Wilhelms-University of Bonn / University Hospital RWTH Aachen | Prof. Dr. D. Wolf Prof. Dr. T. Brümmendorf | Prof. Dr. M. Pfirrmann |
| BreathEase: Randomised controlled trial testing the effectiveness of a new multi-professional Breathlessness service for patients with any advanced disease against usual care | LMU Hospital | Prof. Dr. C. Bausewein | Prof. Dr. U. Mansmann |
| Ceprotin: Case Report: Use of CEPROTIN in Purpura Fulminans | Baxter | Dr. A. Veldmann (Dept. of Pediatrics, Monash University, Melborne, AU) | Prof. Dr. U. Mansmann |
| CHART: Phase IV: Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy | LMU Hospital | Prof. Dr. B. Zwißler Prof. Dr. M. Rehm (Anästhesiologie) | Dr. A. Crispin |
| CML 2004 IMATINIB #068: Treatment of CML patients with Imatinib + hydroxyurea - A phase I/II study | Leipzig University Hospital | Prof. Dr. D. Niederwieser Prof. Dr. T. Lange | Prof. Dr. M. Pfirrmann |
| CML IV: A randomized controlled trial comparing imatinib vs. imatinib plus interferon α vs. imatinib plus low-dose AraC vs. imatinib following failure of interferon α, with an evaluation of the role of allogeneic stem cell transplantation in newly diagnosed CML in the chronic phase | University Hospital Mannheim | Prof. Dr. R. Hehlmann | PD Dr. M. Lauseker-Hao |
| CML V - TIGER: Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotinib or interferon alpha maintenance therapy | Friedrich-Schiller-University Jena | Prof. Dr. A. Hochhaus | Prof. Dr. M. Pfirrmann T. Brenninger-Lang D. Kohn |
| CoSeal: The Use of Fibrin Glue in Lung Surgery | University Rome | A. D'Andrilli, M.D. (Dep. of Thoracic Surgery, Roma, La Sapienza, IT) | Prof. Dr. U. Mansmann |
| DasaHIT: Treatment optimization for patients with CML receiving first-line therapy and patients with resistance to or intolerance of alternative BCR-ABL tyrosine kinase inhibitors (≥second line) | Friedrich-Schiller-University Jena | Prof. Dr. A. Hochhaus | Prof. Dr. M. Pfirrmann |
| Decline: matinib 400 mg daily versus Nilotinib 300 mg twice daily in patients with chronic myeloid leukemia (CML) in 1st chronic phase and confirmed major mo-lecular response (MMR) receiving Imatinib at a dose of 400 mg daily | University Hospital Freiburg | Prof. Dr. N. von Bubnoff | Prof. Dr. U. Mansmann |
| Dentsply: Dentistry, Evaluation of the Clinical Performance of ChemFil™Rock | Dentsply DeTray | wiss. Berater: Prof. Dr. R. Hickel (Zahnerhaltung/ Paradontologie, KUM) | Prof. Dr. U. Mansmann |
| DepressionDC: Electrostimulation for Chronic Depression | Hospital LMU - Hospital for Psychiatry | Prof. Dr. F. Padberg | Dr. A. Crispin |
| EAT2TREAT: Pharmacological therapy of EA2: a placebo-controlled comparison of the efficacy of 4-AP and acetazolamide | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Prof. Dr. U. Mansmann |
| EMPN: Prospective, multicentre observational study to integrate clinical data with genomic investigations with the aim of providing a shared resource of information on epidemiology, genetics, and prognosis of myeloproliferative neoplasms | University Heidelberg | Prof. Dr. A. Reiter | A. Albeer Prof. Dr. M. Pfirrmann |
| EMVERT: Is it stroke? Developing a diagnostic index test to identify stroke as cause of vertigo, dizziness, and imbalance in the emergency room | LMU Hospital - DSGZ | Prof. Dr. K. Jahn | Dr. I. Ricard |
| ENDURE: fficacy and Safety of Ro-PEG-IFN in Maintaining Deep Molecular Remission in Patients with CML Who Discontinue Treatment with an ABL Kinase Inhibitor | University Marburg | Prof. Dr. A. Burchert | Prof. Dr. M. Pfirrmann |
| EORTC 62961/ ESHO RHT-95: Phase III: Hyperthermia for Soft Tissue Sarcomas | EORTC | Prof. Dr. R. Issels (Med. III, Hyperthermie) | R. Laubender |
| ERIC: Enhanced Recovery after Intensive Care | Charité Berlin | Prof. Dr. C. D. Spies | Dr. C. Adrion |
| EschQol: Study on the Health Economics and Quality of Life of Hemophilia Patients | LMU Hospital | Prof. Dr. W. Schramm (Transfusionsmed./ Hämostaseologie) | Prof. Dr. U. Mansmann |
| Evaluation RECIST: Randomized clinical trial, Phase III | Merck | Prof. Dr. U. Mansmann | R. Laubender |
| FACEG: Effect of 4-aminopyridine-SR on gait and falls in cerebellar ataxia - a monocenter, randomized, double-blind, placebo-controlled, 2-way crossover phase II trial | LMU Hospital - DSGZ | Prof. Dr. K. Jahn | Dr. A. Crispin |
| FAM: Observational Study | University Hospital Bonn | Prof. Dr. F.G. Holz | Prof. Dr. U. Mansmann |
| Strengthening and Protecting Families—Dealing with Familial Colorectal Cancer: A registry study combined with an observational study | Federal Ministry for Family, Senior Citizens, Women, and Youth | Prof. Dr. U. Mansmann | Prof. Dr. U. Mansmann |
| FARKOR: Screening for Colorectal Cancer in Individuals with a Family History of the Disease | Innovation Fund Friedrich Burda Foundation | Prof. Dr. U. Mansmann D. Lindörfer Dr. A. Crispin Dr. S. Hoffmann | |
| FIRM-ACT: Randomized Trial to Optimize Treatment for Adrenocortical Tumors | Collaborative group for adrenocortical Carcinoma Treatment (CO-Act) | Prof. Dr. B. Skogseid (UK Uppsala, SWE) | Prof. Dr. H.H. Müller |
| Fr1da: Intervention Study on the Early Detection and Treatment of Children with Type 1 Diabetes | Helmholtz-Center Munich | Prof. Dr. A. G. Ziegler | Prof. Dr. M. Pfirrmann |
| FSME: Phase III: Expansion of the vaccine's approval | Baxter | Prof. Dr. R. Kaiser (Klinikum Pforzheim) PD. Dr. R. Schosser (Baxter) | Prof. Dr. U. Mansmann |
| GERMAIN: Phase II study of Bortezomib, Melphalan, Prednisone (VMP) followed by Lenalidomide maintenance vs. VMP without maintenance in Myeloma patients not eligible to high-dose chemotherapy and autologous stem cell transplantation – a GERman MAINtenance study | Friedrich-Schiller-University Jena | PD Dr. A. Brioli | Prof. Dr. M. Pfirrmann |
| HEAD: Phase III: Therapieoptimierung von Kindern mit BECTS | LMU Hospital | Prof. Dr. F. Heinen (Dr. von Haunersches Kinderspital) | Prof. Dr. U. Mansmann |
| HEAT: Phase III: Optimizing Treatment for Children with BECTS | LMU Hospital - Med III/ Hyperthermie | Prof. Dr. R. Issels | Prof. Dr. U. Mansmann Dr. Y. Xu |
| HEAT 2nd line (former HEAT Pilot): Pilot Phase: Optimizing Treatment for Pancreatic Cancer | LMU Hospital | Prof. Dr. R. Issels (Med. III/ Hyperthermie) | Prof. Dr. U. Mansmann |
| Helicobacter-Studie: Diagnostic Study | LMU Hospital | Prof. Dr. R. Haas (Max von Pettenkofer-Institut) | Prof. Dr. U. Mansmann |
| HPE1: Case Report | TravaCare | Dr. A. Crispin | Prof. Dr. U. Mansmann |
| HTCR: Renovation of a Biomaterial Bank | Stiftung HTCR (Human Tissue & Cell Research) | PD Dr. W. Thasler (Chirurgische Klinik) | Dr. T. Müller |
| ILOCARD:Phase III: Improving Respiratory Function During Cardiac Surgery | LMU Hospital | Prof. Dr. B. Zwißler (Anästhesiologie) | Prof. Dr. H.H. Müller |
| INTESTA1: The Effect of Perioperative Antioxidants and Glutamine on Postoperative Immunosuppression and SIRS Activity | LMU Hospital | Prof. Dr. KW Jauch (Chirurgie) | Prof. Dr. U. Mansmann |
| JointConEval: Effectiveness of a complex intervention to improve social participation in nursing home residents with joint contractures: study protocol of a multicentre clusterrandomised controlled trial | LMU TH Rosenheim MLU Halle | Prof. Dr. U. Mansmann Prof. Dr. M. Müller Prof. Dr. G. Meyer | Prof. Dr. U. Mansmann Lien Le |
| Koloskopie-Screening: Diagnostic Study | LMU Hospital | Prof. Dr. F. Kolligs Prof. Dr. B. Göke (Med.II) | Dr. A. Crispin |
| KOPFregister: Observational Study: Coma Outcomes in Patients Undergoing Early Neurological Rehabilitation | LMU Hospital | PD Dr. A. Bender | Prof. Dr. E. Grill |
| MAURITIUS: Midostaurin in MRD-positive acute myeloid leukemia after allogeneic stem cell transplantation | Friedrich-Schiller-University Jena | Prof. Dr. S. Scholl | Dr. C. Adrion |
| Men-C: Study on Meningococcal Vaccination Coverage | Baxter | Prof. Dr. R. von Kries (Soz. Pädiatrie und Jugendmedizin, LMU) | Prof. Dr. U. Mansmann |
| MICA: Apharese-Studie; Phase II, monocenter, prospective, randomized, controlled trial | LMU Hospital | Prof. Dr. K.G. Parhofer (Med. II) | Dr. A. Crispin |
| MobilE-PHY2: Effectiveness of an evidence-based care pathway to improve mobility and participation in older patients with vertigo and balance disorders in primary care: multicentre cluster-randomised controlled trial | Federal Ministry of Education and Research | Prof. Dr. U. Mansmann Prof. Dr. M. Müller | Dr. A. Crispin |
| MUKIS: Munich Study on Headaches Among High School Students - Intervention Study | LMU Hospital | Prof. Dr. R. von Kries (Soz. Pädiatrie und Jugendmed.) Prof. Dr. F. Heinen (iSPZ) Prof. Dr. A. Straube (Neurologie) | Prof. Dr. U. Mansmann |
| NASPOCAD: Effect of Combined Therapy with Niacin and Statins in Coronary Heart Disease | LMU Hospital | Prof. Dr. W.M. Franz (Med. I, Kardiologie) | Prof. Dr. U. Mansmann |
| PASTURE: Protection against Allergy: Study in Rural Environments | LMU Hospital | Prof. Dr. E. von Mutius (Haunersche Kinderklinik, LMU München) | Dr. T. Müller |
| PINGUIN: A phase II, randomized, double-blind, 2-arm controlled study to evaluate efficacy of the DPPIV-inhibitor Vildagliptin for prevention of type 2 diabetes in women with a recent history of insulin-requiring gestatinal diabetes | Helmholtz Center Munich | Dr. M. Walter Prof. Dr. A.-G. Ziegler | Prof. Dr. M. Pfirrmann |
| Piz Palue: Survey on Fear of Heights | LMU Hospital - DSGZ | Prof. Dr. T. Brandt | Dr. A. Crispin |
| PK-BeST: Pharmacokinetic profile of betahistine blood concentration with and without selegiline: A mono-center, controlled, open-labeled, pharmacokinetic, phase I trial in healthy volunteers | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Dr. A. Al Tawil |
| PRÄP-GO: Prehabilitation for Older Patients with Frailty Syndrome Prior to Elective Surgery | Charité Berlin | Prof. Dr. C. D. Spies | Prof. Dr. U. Mansmann Dr. V. Loidl |
| PROMESA: Phase III: Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) (Double blind, randomised, prospective placebo controlled parallel group study) | LMU Hospital | Dr. J. Levin (Neurologie, LMU), Prof. Dr. G. Höglinger (DZNE, Neurologie TUM) | Dr. I. Ricard |
| PROSPERA: Phase III: Optimization of Treatment for Progressive Supranuclear Palsy (PSP) | LMU Hospital | Prof. Dr. S. Lorenzl (Palliativmedizin) | Dr. A. Crispin |
| PROVEMIG: Prophylactic Treatment of Vestibular Migraine with Metoprolol: A Double-Blind, Placebo-Controlled Study | LMU Hospital - DSGZ | Prof. Dr. M. Strupp | Dr. C. Adrion |
| RAPS: Risk-Adapted Prevention Strategies for Colorectal Cancer | DKFZ Heidelberg | Prof. Dr. H. Brenner | Prof. Dr. U. Mansmann |
| R-HAD: Efficacy and safety of Rituximab, high-dose Ara-C and Dexamethasone (R-HAD) alone or in combination with Bortezomib in patients with relapsed or refractory mantle cell lymphoma | LMU Hospital - Med III | Prof. Dr. M. Dreyling | Prof. Dr. E. Hoster L. Jiang |
| SASSICAIA: Strategies of loading with Prasugrel versus Clopidogrel in PCI-treated biomarker negative angina | LMU Hospital | Prof. Dr. J. Mehilli (Med. I) | Dr. I. Ricard |
| SBK-Rückenschmerz: Observational Study on Back Pain | SBK | PD Dr. D. Irnich (Schmerzambulanz) Prof. U. Mansmann | M. Simang |
| SITAGRAMI: hase III: Recovery from a Myocardial Infarction | LMU Hospital | Prof. Dr. W.M. Franz (Med.I, Kardiologie) | Prof. Dr. U. Mansmann |
| SMART-MI: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction | LMU Hospital - Med I | Prof. Dr. A. Bauer | Dr. A. Al Tawil |
| SPACE II: Observational Study: Stent Comparison Following a Heart Attack | University Hospital Heidelberg | Prof. Dr. W. Hacke (UK Heidelberg) Prof. Dr. H.H. Eckstein (Gefäßchirurgie, TU München) | Prof. Dr. U. Mansmann |
| TEAM: Evidence of Effectiveness: Participation-Oriented Outpatient Intervention | LMU Hospital | PD Dr. A. Bender (Neurologische Klinik, LMU; TZ Burgau) | Prof. Dr. U. Mansmann |
| TravaCare (HPE2): Observational Study on Home Parenteral Nutrition | B. Braun TravaCare | (TravaCare) | Dr. A. Crispin |
| Treat SVDs: Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases: a multicentre, open-label, randomised, crossover trial | LMU Hospital | Prof. Dr. M. Dichgans PD Dr. A. Kopczak | Prof. Dr. U. Mansmann |
| TRIKI: Evaluation of Trigger Points in Tension-Type Headaches in Children | LMU Hospital | Prof. Dr. F. Heinen (Dr. von Haunersches Kinderspital) | Dr. V. Henschel |
| TRINITY: A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThY | LMU Hospital - Med I | PD Dr. U. Grabmaier | Dr. A. Crispin |
| Vasovist1: Diagnostic Study: Improving Artery Visualization (Phase IIa) | LMU Hospital | PD Dr. S. Schönberg (Radiologie) | Prof. Dr. U. Mansmann |
| Vasovist2:Diagnostic Study: Improving Artery Visualization | LMU Hospital | PD Dr. A. Huber (Radiologie) | Prof. Dr. U. Mansmann |
| VesPa: Prophylactic treatment of vestibular paroxysmia with carbamazepine: a prospective, randomized, placebo-controlled, crossover, bi-centre trial | LMU Hospital- DSGZ | Prof. Dr. M. Strupp Prof. Dr. M. Dieterich | Dr. I. Ricard |
| VitD@BPPV: Secondary prophylactic treatment of benign paroxysmal positioning vertigo (BPPV) with vitamin D - a prospective randomized placebo-controlled two-arm multicenter trial | LMU Hospital- DSGZ | Prof. Dr. M. Strupp Prof. Dr. M. Dieterich | Dr. I. Ricard |
| Zweit-Meinung | LMU Hospital | Dr. U. Berger |